Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
A new era of systemic therapy for intermediate and advanced stage hepatocellular carcinoma — Masatoshi Kudo (2020) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
A new era of systemic therapy for intermediate and advanced stage hepatocellular carcinoma
Shared by
Masatoshi Kudo
A new era of systemic therapy for intermediate and advanced stage hepatocellular carcinoma
Editorial Material
2020
en
Authors
Masatoshi Kudo
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2022
New treatment paradigm with systemic therapy in intermediate-stage hepatocellular carcinoma
Masatoshi Kudo
Article
2018
Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyond
Jean‐Luc Raoul
,
Masatoshi Kudo
,
Richard S. Finn
,
Julien Edeline
,
María Reig
,
Peter R. Galle
Article
2024
Systemic Therapy Combined with Locoregional Therapy in Intermediate-stage Hepatocellular Carcinoma
Masatoshi Kudo
Editorial Material
2017
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib.
Masatoshi Kudo
Editorial Material
2020
A New Era in Systemic Therapy for Hepatocellular Carcinoma: Atezolizumab plus Bevacizumab Combination Therapy
Masatoshi Kudo
Discussion(0)
No comments yet. Be the first to comment.